216 related articles for article (PubMed ID: 28367114)
1. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology.
Maphis NM; Jiang S; Binder J; Wright C; Gopalan B; Lamb BT; Bhaskar K
Front Mol Neurosci; 2017; 10():69. PubMed ID: 28367114
[TBL] [Abstract][Full Text] [Related]
2. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
Komuro Y; Xu G; Bhaskar K; Lamb BT
Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
[TBL] [Abstract][Full Text] [Related]
3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
4. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
[TBL] [Abstract][Full Text] [Related]
5. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
Helboe L; Egebjerg J; Barkholt P; Volbracht C
Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
[TBL] [Abstract][Full Text] [Related]
6. Traumatic Brain Injury in hTau Model Mice: Enhanced Acute Macrophage Response and Altered Long-Term Recovery.
Kokiko-Cochran ON; Saber M; Puntambekar S; Bemiller SM; Katsumoto A; Lee YS; Bhaskar K; Ransohoff RM; Lamb BT
J Neurotrauma; 2018 Jan; 35(1):73-84. PubMed ID: 28859549
[TBL] [Abstract][Full Text] [Related]
7. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
[TBL] [Abstract][Full Text] [Related]
8. Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy.
Chang JK; Leso A; Subaiea GM; Lahouel A; Masoud A; Mushtaq F; Deeb R; Eid A; Dash M; Bihaqi SW; Zawia NH
Curr Alzheimer Res; 2018; 15(7):655-663. PubMed ID: 29357795
[TBL] [Abstract][Full Text] [Related]
9. Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.
Barron MR; Gartlon J; Dawson LA; Atkinson PJ; Pardon MC
Front Immunol; 2020; 11():293. PubMed ID: 32194553
[TBL] [Abstract][Full Text] [Related]
10. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
11. The toxin MPTP generates similar cognitive and locomotor deficits in hTau and tau knock-out mice.
Gratuze M; Josset N; Petry FR; Pflieger M; Eyoum Jong L; Truchetti G; Poitras I; Julien J; Bezeau F; Morin F; Samadi P; Cicchetti F; Bretzner F; Planel E
Brain Res; 2019 May; 1711():106-114. PubMed ID: 30641037
[TBL] [Abstract][Full Text] [Related]
12. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.
Rossi F; Geiszler PC; Meng W; Barron MR; Prior M; Herd-Smith A; Loreto A; Lopez MY; Faas H; Pardon MC; Conforti L
Behav Brain Res; 2018 Feb; 339():140-152. PubMed ID: 29175372
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
[TBL] [Abstract][Full Text] [Related]
14. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
15. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
[TBL] [Abstract][Full Text] [Related]
16. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
[TBL] [Abstract][Full Text] [Related]
17. Effects of altered tau expression on dentate granule cell excitability in mice.
Cloyd RA; Koren J; Abisambra JF; Smith BN
Exp Neurol; 2021 Sep; 343():113766. PubMed ID: 34029610
[TBL] [Abstract][Full Text] [Related]
18. Loss of tau rescues inflammation-mediated neurodegeneration.
Maphis N; Xu G; Kokiko-Cochran ON; Cardona AE; Ransohoff RM; Lamb BT; Bhaskar K
Front Neurosci; 2015; 9():196. PubMed ID: 26089772
[TBL] [Abstract][Full Text] [Related]
19. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
20. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
